Los resultados del procedimiento coronario que no es de emergencia fueron similares entre los hospitales en un estudio de Massachusetts
Un estudio halla que los estilos de vida saludables protegen doblemente contra dos importantes grupos de enfermedades
Un fármaco que se usa frecuentemente para tratar la insuficiencia cardiaca crónica podría no aliviar los síntomas en las personas con una forma de la enfermedad
The Montage 2™ is the only approved filter system protecting the carotid arteries capturing embolic debris during intravascular procedures such as Transcatheter Aortic Valve Repair (TAVR).
La extirpación toracoscópica del apéndice auricular izquierdo evita la tromboembolia sin anticoagulación en los pacientes con fibrilación auricular (FA) no valvular.
OrbusNeich today announced that OrbusNeich Medical GmbH and Orbus International B.V., subsidiaries of OrbusNeich Medical, Inc., (collectively, "OrbusNeich") have commenced patent infringement actions in Germany and The Netherlands against Boston Scientific Corporation (BSX) ("Boston Scientific") and its distribution affiliates in those countries
IP protection includes PICSO® method and algorithms that ensure stable and repeatable PICSO® treatment designed to enhance myocardial perfusion following primary PCI in STEMI patients
Loma Vista Medical has established a direct sales force within the United States and a network of seven European distributors working to commercialize the world’s first ultra-precise balloon catheter specifically designed to meet the demands of transcatheter valve procedures.
ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (STJ), a global medical device company, today announced European CE Mark approval of its AMPLATZER™ Amulet™ Left Atrial Appendage Occluder. The Amulet device is used to close the left atrial appendage (LAA) in patients diagnosed with non-valvular atrial fibrillation (AF). According to research, AF leads to an increased risk for stroke. Sealing off the LAA helps prevent the risk of blood clot formation and release, potentially reducing the risk of stroke. The next-generation percutaneous transcatheter device leverages the design and clinical success of the original AMPLATZER™ Cardiac Plug with additional features allowing treatment of a wider range of appendage anatomies. St. Jude Medical will be showcasing the new AMPLATZER Amulet device during the eighteenth annual Boston AF Symposium at booth 319.
SAUSALITO, Calif., Jan. 17, 2013 /PRNewswire/ -- Sanovas Inc., a life science technology company developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has filed with the U.S. Food and Drug Administration for clearance of the company s Vas Zeppelin Smart Catheter for the treatment of chronic pulmonary diseases and lung cancer. The technology would be among the smallest interventional catheters commercially available, allowing physicians to access and deliver therapy to some of the tiniest and most remote passageways in the anatomy.
Madrid, Enero de 2013.- El pasado jueves 10 de enero iVascular celebró su evento de presentación en Madrid. La Galería de Cristal del Palacio Cibeles acogió a los 400 profesionales del sector médico que acudieron a la cita para conocer el proyecto iVascular, una empresa enfocada al diseño y fabricación de dispositivos e implantes en el área cardiovascular, con alto componente tecnológico e innovador.
After drugmakers, it is the turn of stent manufacturers to explore markets overseas. South East Asia, Middle East, Latin America, Eastern Europe — regions where regulatory clearances are relatively easy to get — are particularly attractive for these players.
CHICAGO, Jan. 14, 2013 -- (Healthcare Sales & Marketing Network) -- Phoenix Cardiac Devices, Inc., a medical device company with a novel method of repairing leaky heart valves without open-heart surgery, has enrolled its first patient in a clinical trial aimed at achieving CE Mark approval in Europe.
Madrid, enero de 2013.- Life Vascular Devices, Polytech, Cardiva, Kern Pharma, y Ames; empresas todas ellas de referencia en sus sectores de actividad, han unido sus recursos y know-how para crear la compañía iVascular, dedicada al diseño y fabricación de dispositivos e implantes en el área cardiovascular, con alto componente tecnológico e innovador.
Abbott ($ABT) this week launched a massive U.S. clinical trial for its Absorb drug-eluting bioresorbable vascular scaffold, with plans to enroll up to 2,250 patients. If the results pass muster, they ll support the company s FDA approval bid.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos